UBS Global Healthcare Conference 2025 November 10, 2025 2:45 PM ESTCompany ParticipantsDamien McDonald - CEO & ...
Neuro Sharp as a trusted name within the expanding field of cognitive enhancement supplements. Developed by a team of ...
Under the terms of the agreement, Ceragon will provide a full suite of managed services for the operator's extensive network. The scope includes remote technical support, on-site assistance, and spare ...
In July 2025, the FDA approved Longeveron’s Investigational New Drug (IND) application for its stem cell therapy laromestrocel as a potential treatment for pediatric dilated cardiomyopathy (DCM). The ...
Mehta on what it means to lead a company whose journey has been reflective of the nation's own growth tale, why effective ...